Results Highlights for Interim Results ended 30 June 2026 Revenue reached RMB1,006.5 million, increasing by 21.0% YoY Gross profit amounted to RMB341.7 million, increasing by 0.7% YoY Gross profit margin was 34.0% HONG KONG, Aug. 26, 2026 /PRNewswire/ -- On August 26, 2026, Viva Biotech...
Hence then, the article about viva biotech announces its 2026 interim results ai sparks new paradigm in drug r d cdmo commercial manufacturing accelerates revenue growth was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth )
Also on site :
- Iran-aligned Houthis launch deadly attack on Yemeni presidential palace in escalating campaign against Saudi Arabia
- Martha Stewart’s Reversible 3-Piece Comforter Set Flips From ‘Elegant’ Vines to Bold Stripes, Now Nearly 50% Off
- Miley Cyrus Embraces Being the Anti-Pop Pop Star With Her First ‘Bass Persuades’ Concert at Hollywood Bowl: Concert Review